Medicated Skin Care Products Market 2015-2022 - Global Strategic Business Report 2017 - Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration

DUBLIN, August 23, 2017 /PRNewswire/ --

The "Medicated Skin Care Products - Global Strategic Business Report" report has been added to Research and Markets' offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 120 companies including many key and niche players such as:

- Advanced Dermatology Corporation

- Bayer AG

- Beiersdorf AG

- Chattem, Inc.

- Curatio Healthcare India Pvt. Ltd.

- EltaMD, Inc.

Key Topics Covered:

1. INDUSTRY OVERVIEW
Medicated Skin Care Products: Medical Solutions for Skin Health Needs
Convergence of Beauty and Healthcare
Growth Drivers in a Nutshell
Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver
Major Skin Diseases: Few Fast Facts
Global Market Outlook
Developed Markets: Traditional Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Geographic Regions Ranked by CAGR (Value Sales) for 2015-2022: Asia-Pacific, Rest of World, Latin America, USA, Canada, Europe, and Japan (includes corresponding Graph/Chart)
Competitive Scenario
Leading Players in the Global Medicated Skin Care Products Market
Vendors Emphasize Collaborations
M&A Activity
Select M&A Deals in the Global Medicated Skin Care Products Market in the Recent Past

2. MARKET TRENDS, ISSUES & DRIVERS
Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
Health & Wellness Boosts Demand for Dermocosmetics
Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
Major Anti-Aging Ingredients of Cosmeceuticals
Popular Cosmeceutical Contents
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market
Common Skin Care Cosmeceuticals
Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions
Medicated Skin Care Innovations: Spearheading Growth
Innovations for Acne
Innovations for Actinic Keratosis
Innovations for Tuberous Sclerosis Complex and Angiofibromas
Melasma Treatment Innovations
Onychomycosis Treatment Innovations
Innovations for Alopecia/Hair Loss
Stem Cell Technology: The New Frontier?
Intelligent Scanning for Identifying Beneficial Ingredients
Innovations in Anti-Aging Skin Care
Other Noteworthy Medicated Skin Care Innovations
Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
What's Next in Ingredients?
Innovative Ingredients Gain Focus
Aesthetic Dermatology to Witness Sustained Growth
Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market
Surging Popularity of Multi-Functional Products Promote Market Expansion
Sales of Hydroquinone-free Products Gain Momentum
Facial Wipes Offers Huge Untapped Growth Potential
Women: The Dominant Consumer Cluster for Medicated Skin Care Products
Physiological Differences Entail Need for Male Specific Products
Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
Increasing Environmental Pollution Drive Demand for Anti- Pollution Skin Care Products
Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care

3. REGULATORY FRAMEWORK
The Food, Drug, and Cosmetic Act (FD&C Act)
The Concept of Intended Use
Skin Care Products Continue to Dodge Stringent US FDA Regulations
Regulatory Differences for Skin Care Products and Drugs
FDA getting into the Act
National Advertising Division Concentrates on Big Three

4. PRODUCT OVERVIEW
Introduction
Basic Structure of Skin
Types of Skin
Skin Diseases and their Treatment
Acne
Treatment Options
Causative Factors
Acne Rosacea
Dry Skin
Fungal Infections
Actinic Keratosis
Eczema/Atopic Dermatitis
Psoriasis
Calluses
Friction Blisters
Black Heel and Palm
Tennis Toe
Acne Mechanica
The Crucial Role of Nutrition
Deficiencies and Select Skin Disorders
Dermatitis
Treatment
B Vitamins
Vitamin A
Vitamin C
Eczema
Treatment
Antioxidants
Selenium
Essential Fatty Acids
Psoriasis
Treatment
Vitamin D Analogs
Vitamin A Derivatives
Zinc
Selenium
Essential Fatty Acids

5. PRODUCT LAUNCHES/APPROVALS
ZO® Skin Health Unveils Oclipse® Daily-Use Sun Protection Product
Skinvisible Develops New Topical and Transdermal Cannabis Products
NeoStrata Launches ProSystem Retinol Peel
SkinFix Launches ExtraStrength Adult Skincare Product & Eczema Treatment for Kids
Skinbetter Science Introduces Clinical Skin Care Line
Galderma Receives Positive Opinion from EU Regulatory Agencies for EPIDUO
Adigica Health Launches BioClarity Acne Treatment
FDA Approves Differin Gel
0.1% for OTC Acne Treatment
Medimetriks Submits NDA for Impetigo Treatment Cream
Ceramax Cream by IntraDerm Pharmaceuticals Receives FDA Clearance
FDA Accepts Anacor's NDA for Crisaborole Topical Ointment
Theraderm Launches New Anti-aging Skin Care System
Dapzone Gel by Allergan Receives FDA Approval for Acne Treatment
Bayer HealthCare Launches Finacea Foam for Rosacea Treatment
Galderma's SOOLANTRA® (ivermectin) Cream Approved for Rosacea Patients
Skinvisible Pharmaceuticals Expands Patent Portfolio
Valeant Receives NEA Seal of Approval for CeraVe Baby Products
Galderma Launches Benzac® OTC Acne Solutions
LETI Laboratories' AT4 System Launched in US

6. RECENT INDUSTRY ACTIVITY
ZO Skin Health Bags Global Rights to Suneva Medical's ReFissa®
Galderma Conducts Phase 4 Clinical Studies of New Restylane® Products
CCA Industries Inks License Agreement with Ultimark Products
L'Oréal Purchases Valeant's CeraVe, AcneFree and AMBI Skincare Brands
Otsuka Pharmaceutical to Construct New Facility
Shiseido Receives Regulatory Approval for New Retinol Formulation
Shiseido Acquires Gurwitch Products
Oculus Innovative Sciences Renames itself as Sonoma Pharmaceuticals
Taisho to Acquire KYORIN's Dr. Program Business
Galderma Receives USFDA Approval of Restylane® Refyne and Restylane® Defyne
Moberg Pharma to Acquire Prestige Brands' DermoPlast® Product Line
Nestlé Skin Health and Pinetree Care Group Collaborate on Skin Care Pilot Study
Cadila Acquires Skincare Brand Melgain from Issar Pharma
Chugai and Galderma Enter into Global License Agreement
Pfizer Acquires Anacor Pharmaceuticals
Nestlé Skin Health Enters into Agreement with Guthy-Renker LLC
Galderma Enters into Alliance with Maruho of Japan
Otsuka and Medimetriks Enter Into Licensing Agreement
Unilever to Acquire Clinical Skincare Brand Murad

7. FOCUS ON SELECT GLOBAL PLAYERS

8. GLOBAL MARKET PERSPECTIVE

For more information about this report visit https://www.researchandmarkets.com/research/r7h3zg/medicated_skin

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716